Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients.

Claudia OmariniStefania BettelliCecilia CapreraSamantha ManfrediniFederica CaggiaGiorgia GuaitoliLuca MoscettiAngela TossLaura CortesiShaniko KaleciAntonino MaioranaStefano CascinuPier Franco ConteFederico Piacentini

Published in: Cancer biology & therapy (2018)

BC: breast cancer; MBC: metastatic breast cancer; LR: long responder; EP: early progressor; FFPE: formalin-fixed paraffin-embedded; CNS: central nervous system; PFS: progression free survival; OS: overall survival.

Keyphrases

metastatic breast cancer
free survival
end stage renal disease
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes
young adults
single molecule
cerebrospinal fluid